Patent ductus arteriosus and pulmonary hypertension in a fifteen-year-old boy with congenital rubella syndrome and cerebral palsy: a case report
Main Article Content
Keywords
congenital rubella syndrome, patent ductus arteriosus, pulmonary hypertension, cerebral palsy
Abstract
Introduction: Congenital Rubella Syndrome (CRS) is characterized by congenital cataracts, congenital heart disease (CHD), hearing loss, and developmental delay. It is caused by maternal rubella infection during pregnancy, transmitted transplacentally or via respiratory droplets. CRS carries a high risk of morbidity and mortality, with approximately 10–20% of affected infants dying within the first year of life. This case report describes a 15-year-old boy with CRS who developed pulmonary hypertension (PH) due to a persistent patent ductus arteriosus (PDA).
Case Description: A 15-year-old boy presented with progressive abdominal distension over one week. Initially suspected of having nephritic syndrome, further evaluation revealed bilateral congenital cataracts, non-cyanotic CHD in the form of PDA, sensorineural hearing loss, and developmental delay, fulfilling criteria for CRS. The patient also exhibited delayed motor milestones (walking at age seven) and limb rigidity suggestive of cerebral palsy (CP). Echocardiography confirmed PDA (0.4 cm) with severe tricuspid and aortic regurgitation, and chest X-ray demonstrated cardiomegaly with PH. The PDA was successfully closed using an Amplatzer Duct Occluder (ADO) via catheterization.
Conclusion: This case underscores the importance of early diagnosis and intervention in CRS patients with PDA to prevent irreversible pulmonary vascular disease. Despite a very late PDA closure at age 15, the patient achieved hemodynamic improvement and maintained functional capacity, highlighting that catheter-based closure remains feasible and beneficial even in adolescence. Multidisciplinary care, including timely cardiac intervention and neurodevelopmental support, can improve quality of life in CRS survivors.
References
2. Lanzieri T, Redd S, & Emily Abernathy. Chapter 15: Congenital Rubella Syndrome [Internet]. Centers for Disease Control and Prevention; BMJ Publishing Group. 2020b [updated April 28 2020; cited 2024 August 5]. Available from: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html
3. Lazar M, Perelygina L, Martines R, Greer P, Paddock CD, Peltecu G, et al. Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome. EBioMedicine [Internet]. 2016;3:86–92. Available from: http://dx.doi.org/10.1016/j.ebiom.2015.11.050
4. Awaidy S. Late Clinical Manifestations of Congenital Rubella Syndrome (CRS), an experience from Oman, 1980- 2015. Med Res Arch. 2016;4(8).
5. Burrell CJ, Howard CR, Murphy FA. Pathogenesis of Virus Infections. Fenner and White's Medical Virology. 2017:77–104. doi: 10.1016/B978-0-12-375156-0.00007-2. Epub 2016 November 11. PMCID: PMC7150039.
6. Leung AKC, Hon KL, Leong KF. Rubella (German measles) revisited. Vol. 25, Hong Kong Medical Journal. 2019.
7. Martin, D., & Schoub, B. (2000). Rubella infection in pregnancy. In M. L. Newell & J. McIntyre. (Eds.), Congenital and perinatal infections: Prevention, diagnosis and treatment. Cambridge, UK: Cambridge University Press. pp. 83–95.
8. Enders G, Bäder U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001 May;21(5):362-77. doi: 10.1002/pd.59. Erratum in: Prenat Diagn 2001 Jul;21(7):605. PMID: 11360277.
9. Duszak RS. ‘Congenital rubella syndrome—major review’, Optometry - Journal of the American Optometric Association. 2009; 80(1), pp. 36–43. doi: 10.1016/j.optm.2008.03.006
10. Bouthry E, Picone O, Hamdi G, Grangeot-Keros L, Ayoubi JM, Vauloup-Fellous C. Rubella and pregnancy: Diagnosis, management and outcomes. Vol. 34, Prenatal Diagnosis. 2014.
11. Leonor MC, Mendez MD. Rubella [Internet]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Updated 2023 August 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559040/
12. Naznin SM, Hossain MM. Congenital Rubella Syndrome-a Case Report with Clinical Manifestation and Management Approach. J Natl Inst Ophthalmol. 2023;6(1):54–9.
13. Shukla S, Maraqa NF. StatPearls Publishing. 2023. Congenital Rubella. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507879/#article-19868.s3
14. Kementerian Kesehatan RI. Pedoman Surveilans Congenital Rubella Syndrome (CRS). 2018.
15. Ko JM. Genetic syndromes associated with congenital heart disease. Korean Circ J. 2015;45(5):357–61.
16. Hariyanto D. Profil Penyakit Jantung Bawaan di instalasi Rawat Inap anak RSUP dr.M.Djamil Padang Januari 2008 – Februari 2011. Sari Pediatri. 2016 Nov 17;14(3):152. doi:10.14238/sp14.3.2012.152-7
17. Gunasekaran PK, Shanmugasundaram D, Santhanam S, Verma S, Singh K, Dwibedi B, et al. Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016–22. Lancet Reg Heal - Southeast Asia [Internet]. 2023;16(August):100268. Available from: https://doi.org/10.1016/j.lansea.2023.100268
18. Toizumi M, Do CGT, Motomura H, Do TN, Fukunaga H, Iijima M, et al. Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome. Sci Rep [Internet]. 2019;9(1):1–12. Available from: http://dx.doi.org/10.1038/s41598-019-52936-6
19. Murray JF. Pulmonary edema: pathophysiology and diagnosis. Int J Tuberc Lung Dis. 2011 Feb;15(2):155-60,i.
20. Kataoka M, Yanagisawa R, Yoshino H, Satoh T. Massive Ascites in Pulmonary Arterial Hypertension: Caution with Epoprostenol. Ann Am Thorac Soc. 2013;10(6):726–7.
21. Arvanitaki A, Giannakoulas G, Baumgartner H, Lammers AE. Eisenmenger syndrome: diagnosis, prognosis and clinical management. Heart. 2020;106(21):1638–45.
22. Dimopoulos K. Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus. Eur Respir Rev. 2013;22(130):558–64.
23. Ryan JJ, Suksaranjit P, Hatton N, Bull DA, Wilson BD. Eisenmenger syndrome with unrepaired patent ductus arteriosus. Circulation. 2015;131(16):e409–11.
24. Levinson, W. Review of Medical Microbiology and Immunology. 2016
25. Mekonnen D. Clinically Confirmed Congenital Rubella Syndrome: The Role of Echocardiography. Ethiop J Health Sci. 2017;27(2):197–202.
26. Deng Y, Zhang H, Zhao Z, Du J, Bai R, McNamara PJ. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China. Eur J Pediatr [Internet]. 2022;181(8):3131–40. Available from: https://doi.org/10.1007/s00431-022-04549-x
27. Cunningham F, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. eds. Williams Obstetrics, 26th ed. McGraw Hill; 2022.
28. Philip R, Lamba V, Talati A, Sathanandam S. Pulmonary Hypertension with Prolonged Patency of the Ductus Arteriosus in Preterm Infants. Childern [Internet]. 2020;7(9):139. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552711/
29. Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022;11(17):1–23.
30. Wang K, Pan X, Tang Q, Pang Y. Catheterization therapy vs surgical closure in pediatric patients with patent ductus arteriosus: A meta-analysis. Clin Cardiol. 2014;37(3):188–94.
31. Park MK, Salamat M. Pathophysiology of Cyanotic Congenital Heart Defects. Pediatric Cardiology for Practitioners. 2021. 110 p.
32. Downing KF, Nembhard WN, Rose CE, Andrews JG, Goudie A, Klewer SE, et al. Survival from Birth until Young Adulthood among Individuals with Congenital Heart Defects: CH STRONG. Circulation. 2023;148(7):575–88.
33. Trojnarska O, Grajek S, Katarzyński S, Kramer L. Predictors of mortality in adult patients with congenital heart disease. Cardiol J. 2009;16(4):341-7. PMID: 19653177.
34. Schendel DE. Infection in pregnancy and cerebral palsy. J Am Med Womens Assoc (1972). 2001 Summer;56(3):105-8. PMID: 11506145.
35. Toizumi M, Motomura H, Vo HM, Takahashi K, Pham E, Nguyen HAT, et al. Mortality associated with pulmonary hypertension in congenital rubella syndrome. Pediatrics. 2014 Aug;134(2):e519-26.
36. Reef SE, Plotkin S, Cordero JF, Katz M, Cooper L, Schwartz B, et al. Preparing for Elimination of Congenital Rubella Syndrome (CRS): Summary of a Workshop on CRS Elimination in the United States. Clin Infect Dis [Internet]. 2000 Jul 1;31(1):85–95. Available from: https://doi.org/10.1086/313928
37. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002 Jun;39(12):1890–900.
38. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873–8